Cargando…

Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence

OBJECTIVES: To assess the role of artificial intelligence (AI)-based automated software for detection of diabetic retinopathy (DR) and sight-threatening DR (STDR) by fundus photography taken using a smartphone-based device and validate it against ophthalmologist’s grading. METHODS: Three hundred and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajalakshmi, Ramachandran, Subashini, Radhakrishnan, Anjana, Ranjit Mohan, Mohan, Viswanathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997766/
https://www.ncbi.nlm.nih.gov/pubmed/29520050
http://dx.doi.org/10.1038/s41433-018-0064-9
_version_ 1783331104681361408
author Rajalakshmi, Ramachandran
Subashini, Radhakrishnan
Anjana, Ranjit Mohan
Mohan, Viswanathan
author_facet Rajalakshmi, Ramachandran
Subashini, Radhakrishnan
Anjana, Ranjit Mohan
Mohan, Viswanathan
author_sort Rajalakshmi, Ramachandran
collection PubMed
description OBJECTIVES: To assess the role of artificial intelligence (AI)-based automated software for detection of diabetic retinopathy (DR) and sight-threatening DR (STDR) by fundus photography taken using a smartphone-based device and validate it against ophthalmologist’s grading. METHODS: Three hundred and one patients with type 2 diabetes underwent retinal photography with Remidio ‘Fundus on phone’ (FOP), a smartphone-based device, at a tertiary care diabetes centre in India. Grading of DR was performed by the ophthalmologists using International Clinical DR (ICDR) classification scale. STDR was defined by the presence of severe non-proliferative DR, proliferative DR or diabetic macular oedema (DME). The retinal photographs were graded using a validated AI DR screening software (EyeArt(TM)) designed to identify DR, referable DR (moderate non-proliferative DR or worse and/or DME) or STDR. The sensitivity and specificity of automated grading were assessed and validated against the ophthalmologists’ grading. RESULTS: Retinal images of 296 patients were graded. DR was detected by the ophthalmologists in 191 (64.5%) and by the AI software in 203 (68.6%) patients while STDR was detected in 112 (37.8%) and 146 (49.3%) patients, respectively. The AI software showed 95.8% (95% CI 92.9–98.7) sensitivity and 80.2% (95% CI 72.6–87.8) specificity for detecting any DR and 99.1% (95% CI 95.1–99.9) sensitivity and 80.4% (95% CI 73.9–85.9) specificity in detecting STDR with a kappa agreement of k = 0.78 (p < 0.001) and k = 0.75 (p < 0.001), respectively. CONCLUSIONS: Automated AI analysis of FOP smartphone retinal imaging has very high sensitivity for detecting DR and STDR and thus can be an initial tool for mass retinal screening in people with diabetes.
format Online
Article
Text
id pubmed-5997766
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59977662018-06-20 Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence Rajalakshmi, Ramachandran Subashini, Radhakrishnan Anjana, Ranjit Mohan Mohan, Viswanathan Eye (Lond) Article OBJECTIVES: To assess the role of artificial intelligence (AI)-based automated software for detection of diabetic retinopathy (DR) and sight-threatening DR (STDR) by fundus photography taken using a smartphone-based device and validate it against ophthalmologist’s grading. METHODS: Three hundred and one patients with type 2 diabetes underwent retinal photography with Remidio ‘Fundus on phone’ (FOP), a smartphone-based device, at a tertiary care diabetes centre in India. Grading of DR was performed by the ophthalmologists using International Clinical DR (ICDR) classification scale. STDR was defined by the presence of severe non-proliferative DR, proliferative DR or diabetic macular oedema (DME). The retinal photographs were graded using a validated AI DR screening software (EyeArt(TM)) designed to identify DR, referable DR (moderate non-proliferative DR or worse and/or DME) or STDR. The sensitivity and specificity of automated grading were assessed and validated against the ophthalmologists’ grading. RESULTS: Retinal images of 296 patients were graded. DR was detected by the ophthalmologists in 191 (64.5%) and by the AI software in 203 (68.6%) patients while STDR was detected in 112 (37.8%) and 146 (49.3%) patients, respectively. The AI software showed 95.8% (95% CI 92.9–98.7) sensitivity and 80.2% (95% CI 72.6–87.8) specificity for detecting any DR and 99.1% (95% CI 95.1–99.9) sensitivity and 80.4% (95% CI 73.9–85.9) specificity in detecting STDR with a kappa agreement of k = 0.78 (p < 0.001) and k = 0.75 (p < 0.001), respectively. CONCLUSIONS: Automated AI analysis of FOP smartphone retinal imaging has very high sensitivity for detecting DR and STDR and thus can be an initial tool for mass retinal screening in people with diabetes. Nature Publishing Group UK 2018-03-09 2018-06 /pmc/articles/PMC5997766/ /pubmed/29520050 http://dx.doi.org/10.1038/s41433-018-0064-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rajalakshmi, Ramachandran
Subashini, Radhakrishnan
Anjana, Ranjit Mohan
Mohan, Viswanathan
Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title_full Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title_fullStr Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title_full_unstemmed Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title_short Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
title_sort automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997766/
https://www.ncbi.nlm.nih.gov/pubmed/29520050
http://dx.doi.org/10.1038/s41433-018-0064-9
work_keys_str_mv AT rajalakshmiramachandran automateddiabeticretinopathydetectioninsmartphonebasedfundusphotographyusingartificialintelligence
AT subashiniradhakrishnan automateddiabeticretinopathydetectioninsmartphonebasedfundusphotographyusingartificialintelligence
AT anjanaranjitmohan automateddiabeticretinopathydetectioninsmartphonebasedfundusphotographyusingartificialintelligence
AT mohanviswanathan automateddiabeticretinopathydetectioninsmartphonebasedfundusphotographyusingartificialintelligence